rss
Br J Ophthalmol 2000;84:903-906 doi:10.1136/bjo.84.8.903
  • Original Article
    • Clinical science

Results of intraoperative mitomycin C application in dacryocystorhinostomy

  1. Shu L Liao,
  2. Shine C S Kao,
  3. Jason H S Tseng,
  4. Muh S Chen,
  5. Ping K Hou
  1. Department of Ophthalmology National Taiwan University Hospital, 7, Chung-Shan S Road Taipei, Taiwan
  1. Dr Shu Lang Liaolang89{at}ha.mc.ntu.edu.tw
  • Accepted 13 April 2000

Abstract

AIMS To evaluate the long term results of intraoperative mitomycin C application in dacryocystorhinostomy (DCR) surgery compared with results of the conventional procedure.

METHODS In this prospective randomised controlled study, a total of 88 eyes diagnosed with acquired nasolacrimal duct obstruction were randomly divided into a conventional DCR group and a mitomycin C group in which mitomycin C was used during DCR surgery. The surgical procedures in both groups were exactly the same, except that in the patients in the mitomycin C group, a piece of neurosurgical cottonoid soaked with 0.2 mg/ml mitomycin C was applied to the osteotomy site for 30 minutes. The results of the DCR surgeries were evaluated by objective findings such as irrigation and the height of tear meniscus and subjective symptoms by asking patients the condition of tearing improvement.

RESULTS Among the 44 eyes in the mitomycin C group, 95.5% of patients remained totally symptom free after 10 months of follow up; while in the conventional group, 70.5% of patients were reported to be symptom free and 18% of patients to have an improvement in their symptoms. There was a significant difference between these two groups. As far as objective findings were concerned, there were 41 eyes in the mitomycin C group classified as having a normal and one eye with moderate tear meniscus level, compared with 32 eyes and seven eyes, respectively, in the conventional group. There was also a significant difference between these two groups. The non-patency rate in the mitomycin C group is 4.5% compared with 11.4% in the conventional group. There were no complications such as abnormal nasal bleeding, mucosal necrosis, or infection except one patient with delayed wound healing.

CONCLUSIONS Intraoperative mitomycin C application is effective in increasing the success rate of DCR surgery in standard nasolacrimal duct obstruction, and no significant complications resulted from its use.

Footnotes

    Responses to this article

    • Mitomycin C for external DCR
      • ,
      • Rajat Maheshwari
      Br J Ophthalmol published online September 9, 2009

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Register for free content


    Free trial
    Individuals may register for a free 60 day online trial to all content.

    Free archive
    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.